Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Drug Levels
100%
Disease Activity
100%
Crohn's Disease
100%
Ustekinumab
100%
Operative
27%
Disease-related
27%
Anemia
18%
Type of Surgery
18%
Clinical Disease Activity
18%
Trough Level
18%
Non-surgical Treatment
18%
Endoscopic Disease Activity
18%
Disease States
9%
After Surgery
9%
Clinical Outcomes
9%
Low Risk
9%
C-reactive Protein
9%
Before Surgery
9%
Inflammatory Diseases
9%
Group-based
9%
Endoscopic Outcomes
9%
Outcome-based
9%
Fecal Calprotectin
9%
Harvey-Bradshaw Index
9%
Simple Endoscopic Score for Crohn's Disease
9%
Biochemical Outcome
9%
Rutgeerts
9%
Medicine and Dentistry
Disease Activity
100%
Patient with Crohn's Disease
100%
Ustekinumab
100%
Crohn's Disease
27%
Anemia
18%
Conservative Treatment
18%
Trough Level
18%
Diseases
9%
Retrospective Study
9%
C Reactive Protein
9%
Inflammatory Disorder
9%
Faecal Calprotectin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Activity
100%
Crohn's Disease
100%
Ustekinumab
100%
Anemia
18%
Trough Level
18%
Diseases
9%
Retrospective Study
9%
C Reactive Protein
9%
Inflammatory Disease
9%
Calgranulin
9%
Immunology and Microbiology
Crohn's Disease
100%
Drug Concentration
100%
Ustekinumab
100%
Inflammatory Disorder
9%
C-Reactive Protein
9%